Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease

Pediatric Diabetes

Volumn 15, Issue 2, 2014, Pages 118-126

  Elding Larsson, Helena ^a   Vehik, Kendra ^b   Gesualdo, Patricia ^c   Akolkar, Beena ^d   Hagopian, William ^e   Krischer, Jeffery ^b   Lernmark, Åke ^a   Rewers, Marian ^c   Simell, Olli ^f   She, Jin Xiong ^g   Ziegler, Anette ^h   Haller, Michael J ⁱ  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^e Pacific Northwest Diabetes Research Institute   (United States)

^f UNIVERSITY OF TURKU   (Finland)

^g MEDICAL COLLEGE OF GEORGIA   (United States)

^h INSTITUTE OF EPIDEMIOLOGY   (Germany)

ⁱ UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Autoantibodies; Diagnosis; Follow up studies; TEDDY study; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; GLUCOSE; GLUTAMATE DECARBOXYLASE; HEMOGLOBIN A1C; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR4 ANTIGEN; INSULIN; INSULINOMA ASSOCIATED PROTEIN 2; KETONE; PEPTIDES AND PROTEINS; UNCLASSIFIED DRUG; HISTOCOMPATIBILITY ANTIGEN;

ARTICLE; AUTOIMMUNITY; CHILD; CHILD HOSPITALIZATION; EMERGENCY WARD; ENVIRONMENTAL EXPOSURE; FAMILIAL DISEASE; FEMALE; FINLAND; FIRST DEGREE RELATIVE; FOLLOW UP; GENETIC RISK; GENETIC SCREENING; GENOTYPE; GERMANY; HAPLOTYPE; HIGH RISK POPULATION; HLA SYSTEM; HUMAN; HYPERPHAGIA; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; KETOACIDOSIS; KETONURIA; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PEDIATRICS; POLYDIPSIA; POLYURIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROCONVERSION; STAGING; SWEDEN; UNITED STATES; WEIGHT REDUCTION; BLOOD; CLINICAL TRIAL; COHORT ANALYSIS; DIABETES MELLITUS, TYPE 1; EARLY DIAGNOSIS; EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; MULTICENTER STUDY;

AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; EARLY DIAGNOSIS; EPIDEMIOLOGIC FACTORS; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS; HUMANS; INFANT; MALE;

EID: 84896395566     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12066     Document Type: Article

References (23)

1. IDF. Diabetes Atlas. 2006:2.
2. TEDDY Study Group. The Environmental Determinants of Diabetes in the Young (TEDDY) Study. Ann N Y Acad Sci 2008: 1150: 1-13.
3. Elding Larsson H, Vehik K, Bell R et al; TEDDY Study Group; SEARCH Study Group; Swediabkids Study Group; DPV Study Group; Finnish Diabetes Registry Study Group. Reduced prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up. Diabetes Care 2011: 34: 2347-2352.
4. Ludvigsson J. Immune intervention at diagnosis--should we treat children to preserve beta-cell function? Pediatr Diabetes 2007: 8 (Suppl. 6): 34-39.
5. Bowden SA, Duck MM, Hoffman RP. Young children (<5 yr) and adolescents (>12 yr) with type 1 diabetes mellitus have low rate of partial remission: diabetic ketoacidosis is an important risk factor. Pediatr Diabetes 2008: 9: 197-201.
6. Kiviniemi M, Hermann R, Nurmi J et al; TEDDY Study Group. A high-throughput population screening system for the estimation of genetic risk for type 1 diabetes: an application for the TEDDY (the Environmental Determinants of Diabetes in the Young) study. Diabetes Technol Ther 2007: 9: 460-472.
7. Hagopian WA, Erlich H, Lernmark A et al; TEDDY Study Group. The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants. Pediatr Diabetes 2011: 12: 733-743.
8. Bonifacio E, Yu L, Williams AK et al. Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia. J Clin Endocrinol Metab 2010: 95: 3360-3367.
9. Babaya N, Yu L, Miao D et al. Comparison of insulin autoantibody: polyethylene glycol and micro-IAA 1-day and 7-day assays. Diabetes Metab Res Rev 2009: 25: 665-670.
10. Torn C, Mueller PW, Schlosser M, Bonifacio E, Bingley PJ; Participating Laboratories. Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2. Diabetologia 2008: 51: 846-852.
11. Executive Summary: standards of medical care in diabetes--2011. Diabetes Care 2011: 34 (Suppl. 1): S4-10.
12. Komulainen J, Kulmala P, Savola K et al. Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care 1999: 22: 1950-1955.
13. Andersson C, Larsson K, Vaziri-Sani F et al. The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes. Autoimmunity 2011: 44: 394-405.
14. Quinn M, Fleischman A, Rosner B, Nigrin DJ, Wolfsdorf JI. Characteristics at diagnosis of type 1 diabetes in children younger than 6 years. J Pediatr 2006: 148: 366-371.
15. Rewers A, Klingensmith G, Davis C et al. Presence of diabetic ketoacidosis at diagnosis of diabetes mellitus in youth: the Search for Diabetes in Youth Study. Pediatrics 2008: 121: e1258-e1266.
16. Schober E, Rami B, Waldhoer T; Austrian Diabetes Incidence Study Group. Diabetic ketoacidosis at diagnosis in Austrian children in 1989-2008: a population-based analysis. Diabetologia 2010: 53: 1057-1061.
17. Neu A, Hofer SE, Karges B, Oeverink R, Rosenbauer J, Holl RW; DPV Initiative and the German BMBF Competency Network for Diabetes Mellitus. Ketoacidosis at diabetes onset is still frequent in children and adolescents: a multicenter analysis of 14, 664 patients from 106 institutions. Diabetes Care 2009: 32: 1647-1648.
18. Hekkala A, Knip M, Veijola R. Ketoacidosis at diagnosis of type 1 diabetes in children in northern Finland: temporal changes over 20 years. Diabetes Care 2007: 30: 861-866.
19. Mallare JT, Cordice CC, Ryan BA, Carey DE, Kreitzer PM, Frank GR. Identifying risk factors for the development of diabetic ketoacidosis in new onset type 1 diabetes mellitus. Clin Pediatr (Phila) 2003: 42: 591-597.
20. Barker JM, Goehrig SH, Barriga K et al; DAISY study. Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. Diabetes Care 2004: 27: 1399-1404.
21. Winkler C, Schober E, Ziegler AG, Holl RW. Markedly reduced rate of diabetic ketoacidosis at onset of type 1 diabetes in relatives screened for islet autoantibodies. Pediatr Diabetes 2012: 13: 308-313.
22. Triolo TM, Chase HP, Barker JM; DPT-1 Study Group. Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset. Diabetes Care 2009: 32: 769-773.
23. Nanto-Salonen K, Kupila A, Simell S et al. Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial. Lancet 2008: 372: 1746-1755.